Healthcare Trust Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this 15th day of March, 2024.
| HEALTHCARE TRUST, INC. | |
| By | /s/ Michael Anderson |
| Michael Anderson | |
| Chief Executive Officer(Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Capacity | Date |
|---|---|---|
| /s/ Leslie D. Michelson | Non-Executive Chairman of the Board of Directors, Independent Director | March 15, 2024 |
| Leslie D. Michelson | ||
| /s/ Scott M. Lappetito | Chief Financial Officer, Treasurer and Secretary | March 15, 2024 |
| Scott M. Lappetito | (Principal Financial Officer and Principal Accounting Officer) | |
| /s/ Michael Anderson | Chief Executive Officer | March 15, 2024 |
| Michael Anderson | ||
| /s/ Elizabeth K. Tuppeny | Independent Director | March 15, 2024 |
| Elizabeth K. Tuppeny | ||
| /s/ Edward G. Rendell | Independent Director | March 15, 2024 |
| Edward G. Rendell | ||
| /s/ B.J. Penn | Independent Director | March 15, 2024 |
| B.J. Penn | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2023, 2022 and 2021 | F-5 |
| Consolidated Statements of Changes in Equity for the Years Ended December 31, 2023, 2022 and 2021 | F-6 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022 and 2021 | F-7 |
| Notes to Consolidated Financial Statements | F-9 |
| Financial Statement Schedule: | |
| Schedule III — Real Estate and Accumulated Depreciation as of December 31, 2023 | F-52 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.